Efficacy of Vesicular Stomatitis Virus–Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine

(2017) Jason A. Regules et al.   NEW ENGLAND JOURNAL OF MEDICINE

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

(2016) Travis K. Warren et al.   NATURE

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

(2016) Selidji T. Agnandji et al.   NEW ENGLAND JOURNAL OF MEDICINE

Progression of Ebola Therapeutics During the 2014–2015 Outbreak

(2016) Emelissa J. Mendoza et al.   TRENDS IN MOLECULAR MEDICINE

Emergency Postexposure Vaccination With Vesicular Stomatitis Virus–Vectored Ebola Vaccine After Needlestick

(2015) Lilin Lai et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus–Based Filovirus Vaccines

(2015) Andrea Marzi et al.   JOURNAL OF INFECTIOUS DISEASES

Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection: Table 1.

(2015) Thomas W. Geisbert et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

(2015) Ana Maria Henao-Restrepo et al.   LANCET

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

(2015) Angela Huttner et al.   LANCET INFECTIOUS DISEASES

Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates

(2015) Emily P. Thi et al.   NATURE

Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus

(2015) Chad E. Mire et al.   NATURE

VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain

(2015) A. Marzi et al.   SCIENCE

Characterization of Clinical and Immunological Parameters During Ebola Virus Infection of Rhesus Macaques

(2015) Karen Martins et al.   VIRAL IMMUNOLOGY

Ebola virus vaccines: an overview of current approaches

(2014) Andrea Marzi et al.   Expert Review of Vaccines

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

(2014) Xiangguo Qiu et al.   NATURE

Emergence of Zaire Ebola Virus Disease in Guinea

(2014) Sylvain Baize et al.   NEW ENGLAND JOURNAL OF MEDICINE

Post-exposure therapy of filovirus infections

(2014) Gary Wong et al.   TRENDS IN MICROBIOLOGY

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

(2013) A. Marzi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany

(2011) Stephan Günther et al.   JOURNAL OF INFECTIOUS DISEASES

Host Response Dynamics Following Lethal Infection of Rhesus Macaques With Zaire ebolavirus

(2011) Hideki Ebihara et al.   JOURNAL OF INFECTIOUS DISEASES

Enzyme-Linked Immunosorbent Assay for Detection of Filovirus Species-Specific Antibodies

(2010) E. Nakayama et al.   Clinical and Vaccine Immunology

Ebola haemorrhagic fever

(2010) Heinz Feldmann et al.   LANCET

Automated minimization of steric clashes in protein structures

(2010) Srinivas Ramachandran et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Ebolavirus VP24 Binding to Karyopherins Is Required for Inhibition of Interferon Signaling

(2009) M. Mateo et al.   JOURNAL OF VIROLOGY